Literature DB >> 12374768

Functional association of the parkin gene promoter with idiopathic Parkinson's disease.

Andrew B West1, Demetrius Maraganore, Julia Crook, Tim Lesnick, Paul J Lockhart, Kristen M Wilkes, Gregory Kapatos, John A Hardy, Matt J Farrer.   

Abstract

Loss-of-function mutations in the parkin gene were first identified in autosomal recessive juvenile parkinsonism (AR-JP). Subsequently, parkin mutations were found in many early-onset patients with Parkinson's disease (PD) (<45 years at onset). We hypothesized that parkin gene expression also may contribute to the age-associated risk of idiopathic PD (>50 years at onset). Two single-nucleotide polymorphisms within the parkin core promoter have been identified and assessed. We show one of the variants, -258 T/G, is located in a region of DNA that binds nuclear protein from human substantia nigra in vitro and functionally affects gene transcription. Furthermore, the -258 T/G polymorphism is genetically associated with idiopathic PD, as assessed in a large population-based series of cases and controls. Our results further implicate the parkin gene in the development of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374768     DOI: 10.1093/hmg/11.22.2787

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

1.  Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association.

Authors:  E K Tan; K Y Puong; D K Y Chan; K Yew; S Fook-Chong; H Shen; P W Ng; J Woo; Y Yuen; R Pavanni; M C Wong; K Puvan; Y Zhao
Journal:  Hum Genet       Date:  2005-10-22       Impact factor: 4.132

Review 2.  Neurodegenerative disorders: Parkinson's disease and Huntington's disease.

Authors:  S M Hague; S Klaffke; O Bandmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

3.  Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease.

Authors:  Owen A Ross; Kristoffer Haugarvoll; Jeremy T Stone; Michael G Heckman; Linda R White; Jan O Aasly; J Mark Gibson; Timothy Lynch; Zbigniew K Wszolek; Ryan J Uitti; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2007-04-02       Impact factor: 4.891

4.  Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

Authors:  Cheng Wang; Ruifeng Lu; Xuezhi Ouyang; Michelle W L Ho; William Chia; Fengwei Yu; Kah-Leong Lim
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

5.  Common variants in PARK loci and related genes and Parkinson's disease.

Authors:  Sun Ju Chung; Sebastian M Armasu; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Sarah J Lincoln; Alexandra I Ortolaza; Matthew J Farrer; Julie M Cunningham; Walter A Rocca; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2010-12-13       Impact factor: 10.338

6.  Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on α-synuclein protein levels.

Authors:  Emmanuel González-Barbosa; Rosario García-Aguilar; Libia Vega; María Asunción Cabañas-Cortés; Frank J Gonzalez; José Segovia; Sara L Morales-Lázaro; Bulmaro Cisneros; Guillermo Elizondo
Journal:  Biochem Pharmacol       Date:  2019-08-09       Impact factor: 5.858

7.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

Authors:  Jessie Theuns; Nathalie Brouwers; Sebastiaan Engelborghs; Kristel Sleegers; Veerle Bogaerts; Ellen Corsmit; Tim De Pooter; Cornelia M van Duijn; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

8.  Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease.

Authors:  E K Tan; H Shen; J M M Tan; K L Lim; S Fook-Chong; W P Hu; M C Paterson; V R Chandran; K Yew; C Tan; Y Yuen; R Pavanni; M C Wong; K Puvan; Y Zhao
Journal:  Neurogenetics       Date:  2005-08-06       Impact factor: 2.660

9.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

10.  Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin.

Authors:  Jerome A Roth; Balakrishnan Ganapathy; Andrew J Ghio
Journal:  Toxicol In Vitro       Date:  2012-07-26       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.